Possible novel biomarkers of organ involvement in systemic lupus erythematosus

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical Rheumatology

• Publication date

  2014-03-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10067-014-2560-zPMID 24599678
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-Mullerian Hormone: A New Marker of Ovarian Function

  2014cited by this paper
• Anti-müllerian hormone and ovarian reserve in systemic lupus erythematosus.

  2013cited by this paper
• Autoantibodies against galectins are associated with antiphospholipid syndrome in patients with systemic lupus erythematosus.

  2013cited by this paper
• Combination of anti-C1q and anti-dsDNA antibodies is associated with higher renal disease activity and predicts renal prognosis of patients with lupus nephritis.

  2012cited by this paper
• Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide.

  2012cited by this paper
• Subclinical impairment of ovarian reserve in juvenile systemic lupus erythematosus after cyclophosphamide therapy.

  2012cited by this paper
• Type I IFN system in the development and manifestations of SLE

  2012cited by this paper
• Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP.

  2012cited by this paper
• Autoantibodies against galectin-2 peptides as biomarkers for the antiphospholipid syndrome

  2012cited by this paper
• NR2-reactive antibody decreases cell viability through augmentation of Ca(2+) influx in systemic lupus erythematosus.

  2011cited by this paper
• The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?

  2011cited by this paper
• Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares

  2011cited by this paper
• Faculty Opinions recommendation of C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes.

  2011influential reference
• Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers

  2011cited by this paper
• C1q regulation of dendritic cell development from monocytes with distinct cytokine production and T cell stimulation.

  2011influential reference
• Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: Evaluation by using anti-Muellerian hormone

  2011cited by this paper
• Anti-NR2A antibody as a predictor for neuropsychiatric systemic lupus erythematosus.

  2011cited by this paper
• Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States.

  2011cited by this paper
• Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms

  2010cited by this paper
• Infiltrating dendritic cells contribute to local synthesis of C1q in murine and human lupus nephritis.

  2010cited by this paper
• Clinical utility of measurement of anti-mullerian hormone in reproductive endocrinology.

  2010cited by this paper
• Complement: a key system for immune surveillance and homeostasis

  2010cited by this paper
• Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system

  2010cited by this paper
• SLE diagnosis and treatment: when early is early.

  2010cited by this paper
• Anti-CD43 and anti-galectin-1 autoantibodies in patients with systemic lupus erythematosus

  2010cited by this paper
• C1q Deficiency Leads to the Defective Suppression of IFN-α in Response to Nucleoprotein Containing Immune Complexes

  2010cited by this paper
• Assessment of ovarian function with anti-Müllerian hormone in systemic lupus erythematosus patients undergoing hematopoietic stem cell transplant.

  2009cited by this paper
• Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells

  2009cited by this paper
• Autoantibodies against C1q in Systemic Lupus Erythematosus Are Antigen-Driven1

  2009cited by this paper
• C1q enhances IFN-gamma production by antigen-specific T cells via the CD40 costimulatory pathway on dendritic cells.

  2009cited by this paper
• Autoantibodies against galectin-8: their specificity, association with lymphopenia in systemic lupus erythematosus and detection in rheumatoid arthritis and acute inflammation

  2009cited by this paper
• C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis.

  2009influential reference
• Depression is an early disease manifestation in lupus-prone MRL/lpr mice.

  2009cited by this paper
• Suppression of Autoimmune Diabetes by Soluble Galectin-11

  2009cited by this paper
• Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis

  2008influential reference
• Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition.

  2008cited by this paper
• Autoantibodies against Complement C1q Specifically Target C1q Bound on Early Apoptotic Cells1

  2008cited by this paper
• Serum and Cerebrospinal Fluid Autoantibodies in Patients with Neuropsychiatric Lupus Erythematosus. Implications for Diagnosis and Pathogenesis

  2008cited by this paper
• Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus.

  2008cited by this paper
• Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis.

  2008cited by this paper
• Clinical Thrombotic Manifestations in SLE Patients With and Without Antiphospholipid Antibodies: A 5-year Follow-up

  2007cited by this paper
• Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death

  2007cited by this paper
• Dissecting the pathophysiologic role of endogenous lectins: glycan-binding proteins with cytokine-like activity?

  2007cited by this paper
• New insights into central nervous system lupus: A clinical perspective

  2007cited by this paper
• Association of cerebrospinal fluid anti-ribosomal P protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus

  2007cited by this paper
• Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.

  2006cited by this paper
• Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational studies using recombinant globular head modules of human C1q A, B, and C chains.

  2006cited by this paper
• High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.

  2006cited by this paper
• Human lupus autoantibodies against NMDA receptors mediate cognitive impairment

  2006cited by this paper
• Galectin-1 Suppresses Autoimmune Retinal Disease by Promoting Concomitant Th2- and T Regulatory-Mediated Anti-Inflammatory Responses1

  2006cited by this paper
• Immunity and behavior: antibodies alter emotion.

  2006cited by this paper
• Anti-Müllerian hormone: a new marker for ovarian function.

  2006cited by this paper
• Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus.

  2006cited by this paper
• Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus

  2005cited by this paper
• The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders

  2005cited by this paper
• Galectin-1 Sensitizes Resting Human T Lymphocytes to Fas (CD95)-mediated Cell Death via Mitochondrial Hyperpolarization, Budding, and Fission*

  2005cited by this paper
• Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors

  2005cited by this paper
• Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy.

  2005influential reference
• Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus

  2004cited by this paper
• Cognition and immunity; antibody impairs memory.

  2004cited by this paper
• beta2-glycoprotein I, the playmaker of the antiphospholipid syndrome.

  2004cited by this paper
• Structure and activation of the C1 complex of complement: unraveling the puzzle.

  2004cited by this paper
• Pathogenesis of systemic lupus erythematosus

  2003cited by this paper
• Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study.

  2003cited by this paper
• Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG.

  2003cited by this paper
• Antiphospholipid syndrome: an overview.

  2003cited by this paper
• FcγRIIa Is Expressed on Natural IFN-α-Producing Cells (Plasmacytoid Dendritic Cells) and Is Required for the IFN-α Production Induced by Apoptotic Cells Combined with Lupus IgG 1

  2003cited by this paper
• Animal lectins: a historical introduction and overview.

  2002cited by this paper
• The antiphospholipid syndrome.

  2002cited by this paper
• Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients.

  2002influential reference
• A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus

  2001cited by this paper
• Pathogenesis of systemic lupus erythematosus (SLE)

  2001cited by this paper
• International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.

  1999cited by this paper
• Recombinant Galectin-1 and Its Genetic Delivery Suppress Collagen-Induced Arthritis via T Cell Apoptosis

  1999cited by this paper
• The glutamate receptor ion channels.

  1999cited by this paper
• Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

  1997cited by this paper
• Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus.

  1997cited by this paper
• Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests.

  1995cited by this paper
• Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study.

  1990cited by this paper
• Recombinant human beta-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis.

  1990cited by this paper
• Recombinant human β-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis

  1990cited by this paper
• Isolation and characterization of maerophage‐derived C1q and its similarities to serum C1q

  1986cited by this paper
• Characterization of C1q-binding IgG complexes in systemic lupus erythematosus.

  1984cited by this paper

• miR-452-5p promotes systemic lupus erythematosus-induced inflammatory responses by downregulating RBL2 and impairing Treg development

  2026cites this paper
• Anti-TCP1 Antibody Is a Potential Biomarker for Diagnosing Systemic Lupus Erythematosus

  2024cites this paper
• Do novel inflammation biomarkers arising from routine complete blood count play a role in patients with systemic lupus erythematosus?

  2024cites this paper
• Multiple autoimmune syndrome: Clinical, immunological and genotypic characterization.

  2023cites this paper
• Impact of Corticosteroids on the Proportions of Circulating Tfh Cell Subsets in Patients With Systemic Lupus Erythematous

  2022cites this paper
• A Contemporary Update on the Diagnosis of Systemic Lupus Erythematosus

  2022cites this paper
• Smell and Autoimmunity—State of the Art

  2019cites this paper
• Preliminary study on the changes of ovarian reserve, menstruation, and lymphocyte subpopulation in systemic lupus erythematosus (SLE) patients of childbearing age

  2018cites this paper
• Anti-Double-Stranded DNA Isotypes and Anti-C1q Antibody Improve the Diagnostic Specificity of Systemic Lupus Erythematosus

  2018cites this paper
• Psycho-rheumatic Integration in Systemic Lupus Erythematosus: An Insight into Antibodies Causing Neuropsychiatric Changes

  2018cites this paper
• Ovarian reserve is preserved in Behçet's disease

  2017cites this paper
• Investigation of Transcriptional Gene Profiling in Normal Murine Hair Follicular Substructures Using Next-Generation Sequencing to Provide Potential Insights into Skin Disease

  2016cites this paper
• Circulating Angiogenic T Cells and Their Subpopulations in Patients with Systemic Lupus Erythematosus

  2016cites this paper
• Novel Phospholipid-Protein Conjugates Allow Improved Detection of Antibodies in Patients with Autoimmune Diseases

  2016cites this paper
• Advances in the diagnosis and classification of systemic lupus erythematosus

  2016cites this paper
• Reduction of Cerebral and Corpus Callosum Volumes in Childhood‐Onset Systemic Lupus Erythematosus: A Volumetric Magnetic Resonance Imaging Analysis

  2016cites this paper
• Autoantibodies in SLE: Specificities, Isotypes and Receptors

  2016cites this paper
• Autoantibodies as Biomarkers of Systemic Lupus Erythematosus

  2016cites this paper
• Mean platelet volume: a novel diagnostic factor of systemic lupus erythematosus?

  2015cites this paper
• Evaluation of Ovarian Reserve with Anti-Müllerian Hormone in Familial Mediterranean Fever

  2015cites this paper
• 한국인 루푸스 임상연구의 현재와 미래

  2014cites this paper
• The Present and Future of Clinical Research for Korean Lupus Patients

  2014cites this paper